Trademark: 86944319
Word
ONTREZZA
Status
Dead
Status Code
604
Status Date
Monday, March 27, 2017
Serial Number
86944319
Mark Type
4000
Filing Date
Thursday, March 17, 2016
Published for Opposition
Tuesday, August 23, 2016
Abandoned Date
Monday, March 27, 2017

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system (CNS) disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile antibiotic and anti-inflammatory ointments; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
The wording "ONTREZZA" has no meaning in a foreign language.

Trademark Events
Mar 27, 2017
Abandonment Notice Mailed - Inter Partes Decision
Mar 27, 2017
Abandonment - After Inter Partes Decision
Mar 27, 2017
Opposition Terminated No. 999999
Mar 27, 2017
Opposition Dismissed No. 999999
Dec 20, 2016
Opposition Instituted No. 999999
Sep 13, 2016
Extension Of Time To Oppose Received
Aug 23, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 23, 2016
Published For Opposition
Aug 3, 2016
Notification Of Notice Of Publication E-Mailed
Jul 15, 2016
Law Office Publication Review Completed
Jul 12, 2016
Assigned To Lie
Jun 29, 2016
Approved For Pub - Principal Register
Jun 29, 2016
Examiner's Amendment Entered
Jun 29, 2016
Notification Of Examiners Amendment E-Mailed
Jun 29, 2016
Examiners Amendment E-Mailed
Jun 29, 2016
Examiners Amendment -Written
Jun 27, 2016
Notification Of Non-Final Action E-Mailed
Jun 27, 2016
Non-Final Action E-Mailed
Jun 27, 2016
Non-Final Action Written
Jun 27, 2016
Assigned To Examiner
Mar 22, 2016
New Application Office Supplied Data Entered In Tram
Mar 21, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24